FDA Clearance Tracker · K243417
RelieVRx
Last checked: Nov 20, 2026Latest source record: Dec 4, 2024 (this decision)Source: openFDAMethods & limitations
Decided
Dec 4, 2024
Substantially Equivalent
Time to decision
30 days
Received Nov 4, 2024. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Special
Device class
Class II
The decision
- FDA number
- K243417
- Device name
- RelieVRx
- Applicant
- Appliedvr
- Applicant location
- Van Nuys, CA
- Received
- Nov 4, 2024
- Decided
- Dec 4, 2024
- Decision
- Substantially Equivalent
- Submission type
- Special
Device type
- Device class
- Class II
- Regulation
- 21 CFR 890.5800
- Specialty
- Neurology & Neurosurgery
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code QRA. The earliest in FDA's data is DEN210014, decided Nov 16, 2021.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K243417
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Appliedvr
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- RelieVRx (Pico G3)510(k)
K251519 · Decided Aug 13, 2025 · 89 days after receipt
Device type: Virtual Reality Behavioral Therapy Device For Pain Relief (QRA) · Neurology & Neurosurgery
- EaseVRxNew device typeBreakthroughDe Novo
DEN210014 · Decided Nov 16, 2021 · 231 days after receipt
Device type: Virtual Reality Behavioral Therapy Device For Pain Relief (QRA) · Neurology & Neurosurgery
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.